Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328731 · ClinicalTrials.gov registry record · Phase 1
Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).
A Phase 1 study, sponsored by Nambudripad's Allergy Research Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00328731 is a Phase 1 study that has completed, run by Nambudripad's Allergy Research Foundation. The registered enrollment target is 26 participants.
The verdict
NCT00328731, a Phase 1 study, has completed, sponsored by Nambudripad's Allergy Research Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
We sought to determine the efficacy of NAET® in permanently eliminating milk allergy for a sample of patients. We hypothesize that the subjects in the experimental group will show similar level of allergies and sensitivities initially on all nine diagnostic measures used here. After receiving the NAET treatments, the Experimental group will demonstrate a significant reduction in the milk sensitivities and allergies when compared to the control group at the final evaluation using same diagnostic measures.
Interventions
- PROCEDURE Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00328731
The ClinicalTrials.gov registry entry for NCT00328731 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nambudripad's Allergy Research Foundation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procedure is the first listed.
NCT00328731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00328731 about?
NCT00328731 is a clinical study titled "Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques).". We sought to determine the efficacy of NAET® in permanently eliminating milk allergy for a sample of patients. We hypothesize that the subjects in the experimental group will show similar level of allergies and sensitivities initially on all nine diagnostic measures used here. After receiving the N...
What is the current status of trial NCT00328731?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2005-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00328731?
The interventions under investigation include: Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00328731?
This trial is sponsored by Nambudripad's Allergy Research Foundation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.